These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 11740143)
1. Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatment. Fulghesu AM; Apa R; Belosi C; Ciampelli M; Selvaggi L; Cucinelli F; Caruso A; Mancuso S; Lanzone A Horm Res; 2001; 55(5):224-8. PubMed ID: 11740143 [TBL] [Abstract][Full Text] [Related]
2. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. Bayram N; van Wely M; van Der Veen F Cochrane Database Syst Rev; 2001; (2):CD002121. PubMed ID: 11406034 [TBL] [Abstract][Full Text] [Related]
3. A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome. Homburg R; Levy T; Ben-Rafael Z Fertil Steril; 1995 Apr; 63(4):729-33. PubMed ID: 7890055 [TBL] [Abstract][Full Text] [Related]
4. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial. Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878 [TBL] [Abstract][Full Text] [Related]
5. [Chronic low dose follicle stimulating hormone step-up regimen in the treatment of polycystic ovary syndrome related anovulatory infertility with clomiphene resistance]. Chen W; Zhang Y; Dai Q Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):588-90. PubMed ID: 11372406 [TBL] [Abstract][Full Text] [Related]
6. Recombinant FSH in alternative doses or versus urinary gonadotrophins for ovulation induction in subfertility associated with polycystic ovary syndrome: a systematic review based on a Cochrane review. van Wely M; Bayram N; van der Veen F Hum Reprod; 2003 Jun; 18(6):1143-9. PubMed ID: 12773438 [TBL] [Abstract][Full Text] [Related]
7. Ovulation induction using low-dose step-up rFSH in Vietnamese women with polycystic ovary syndrome. Lan VT; Norman RJ; Nhu GH; Tuan PH; Tuong HM Reprod Biomed Online; 2009 Apr; 18(4):516-21. PubMed ID: 19400993 [TBL] [Abstract][Full Text] [Related]
8. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain. Burgués S; Hum Reprod; 2001 Dec; 16(12):2525-32. PubMed ID: 11726569 [TBL] [Abstract][Full Text] [Related]
10. Oligoovulatory and anovulatory cycles in women with polycystic ovary syndrome (PCOS): what's the difference? Burgers JA; Fong SL; Louwers YV; Valkenburg O; de Jong FH; Fauser BC; Laven JS J Clin Endocrinol Metab; 2010 Dec; 95(12):E485-9. PubMed ID: 20843954 [TBL] [Abstract][Full Text] [Related]
11. Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements. Homburg R; Howles CM Hum Reprod Update; 1999; 5(5):493-9. PubMed ID: 10582786 [TBL] [Abstract][Full Text] [Related]
12. Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group. Coelingh Bennink HJ; Fauser BC; Out HJ Fertil Steril; 1998 Jan; 69(1):19-25. PubMed ID: 9457926 [TBL] [Abstract][Full Text] [Related]
13. Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP). Lenton E; Soltan A; Hewitt J; Thomson A; Davies W; Ashraf N; Sharma V; Jenner L; Ledger W; McVeigh E Hum Reprod; 2000 May; 15(5):1021-7. PubMed ID: 10783345 [TBL] [Abstract][Full Text] [Related]
14. Comparison of two different starting doses of recombinant follicle stimulating hormone (rFSH) for intrauterine insemination (IUI) cycles in non-obese women with polycystic ovary syndrome (PCOS): a retrospective cohort study. Seckin B; Yumusak OH; Tokmak A J Obstet Gynaecol; 2021 Nov; 41(8):1234-1239. PubMed ID: 33624571 [TBL] [Abstract][Full Text] [Related]
15. Ovulation induction with low dose alternate day recombinant follicle stimulating hormone (Puregon). Buckler HM; Robertson WR; Anderson A; Vickers M; Lambert A Hum Reprod; 1999 Dec; 14(12):2969-73. PubMed ID: 10601080 [TBL] [Abstract][Full Text] [Related]
16. Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis. Revelli A; Poso F; Gennarelli G; Moffa F; Grassi G; Massobrio M Reprod Biol Endocrinol; 2006 Jul; 4():38. PubMed ID: 16848893 [TBL] [Abstract][Full Text] [Related]
17. Ovulation induction with urinary FSH or recombinant FSH in polycystic ovary syndrome patients: a prospective randomized analysis of cost-effectiveness. Gerli S; Casini ML; Unfer V; Costabile L; Mignosa M; Di Renzo GC Reprod Biomed Online; 2004 Nov; 9(5):494-9. PubMed ID: 15588465 [TBL] [Abstract][Full Text] [Related]
18. Chronic ultra-low dose follicle-stimulating hormone regimen for patients with polycystic ovary syndrome: one click, one follicle, one pregnancy. Orvieto R; Homburg R Fertil Steril; 2009 Apr; 91(4 Suppl):1533-5. PubMed ID: 18990384 [TBL] [Abstract][Full Text] [Related]
19. Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women and WHO group II anovulatory infertile patients. Balasch J; Fábregues F; Peñarrubia J; Creus M; Vidal R; Casamitjana R; Manau D; Vanrell JA J Assist Reprod Genet; 1998 Oct; 15(9):552-9. PubMed ID: 9822984 [TBL] [Abstract][Full Text] [Related]
20. Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens. Balasch J; Fábregues F; Creus M; Puerto B; Peñarrubia J; Vanrell JA Hum Reprod; 2001 Apr; 16(4):652-6. PubMed ID: 11278212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]